Myasthenia gravis in the Republic of Bashkortostan: analysis of clinical and functional features

Cover Page

Cite item

Full Text

Abstract

Background. Myasthenia gravis (MG) is a chronic autoimmune disease that significantly affects patients’ quality of life. Studying the regional characteristics of MG is important for optimizing medical care.

Aim. To study the socio-demographic and clinical-functional characteristics of patients with MG in the Republic of Bashkortostan.

Materials and methods. A cross-sectional study was conducted based on data from the Republican Medical Information and Analytical System as of 01.01.2024. Data from 249 patients diagnosed with MG (G70.0) were analyzed.

Results. Data from 249 patients with MG were analyzed. Women (70.3 %) and individuals over 50 years of age (69 %) predominated among them. The mean age of disease onset was 43.1 years. The generalized form of MG was diagnosed in 86.7 % of patients and was significantly more common in women. Approximately half of the patients had a disability. During the year, 63.4 % of patients visited a neurologist on an outpatient basis, and 52.2 % received inpatient treatment. All patients received pyridostigmine bromide, in combination with glucocorticoids – 66.6 %, and with cytostatics – 2.8 %. Thymectomy was performed in 12.4 % of patients. High comorbidity was noted: on average, there were 3 comorbid conditions per patient.

Conclusion. The study results demonstrate the high medical and social significance of MG in the Republic of Bashkortostan. Enhancement of outpatient medical care for patients with myasthenia gravis in the Republic of Bashkortostan and implementation of more personalized treatment approaches are required.

About the authors

Adel V. Berg

Bashkir State Medical University, Ministry of Health of Russia

Author for correspondence.
Email: adel.basharova@mail.ru
ORCID iD: 0000-0002-6782-6064
Russian Federation, 3 Lenina St., Ufa, 450008, Republic of Bashkortostan

M. A. Kutlubaev

Bashkir State Medical University, Ministry of Health of Russia

Email: adel.basharova@mail.ru
ORCID iD: 0000-0003-1001-2024
Russian Federation, 3 Lenina St., Ufa, 450008, Republic of Bashkortostan

References

  1. Juel V.C. Autoimmune myasthenia gravis. Continuum (Minneap Minn) 2025;31(5):1270–302. doi: 10.1212/cont.0000000000001612
  2. Alekseeva T.M., Kryuchkova V.V., Stuchevskaya T.R., Khalmurzina A.N. Epidemiologic studies of myasthenia gravis: literature review. Nervno-myshechnye bolezni = Neuromuscular Diseases 2018;8 (3):12–8. (In Russ.). doi: 10.17650/2222-8721-2018-8-3-12-18
  3. Gilhus N.E., Breiner A. Epidemiology of myasthenia gravis. Int Rev Neurobiol 2025;182:161–96. doi: 10.1016/bs.irn.2025.04.028
  4. Berg A.V., Kutlubaev M.A. Analysis of the incidence of myasthenia gravis in the Republic of Bashkortostan during 2013–2022. Rossiyskiy nevrologicheskiy zhurnal = Russian Neurological Journal 2025;30(4): 18–21. (In Russ.) . doi: 10.30629/2658-7947-2025-30-4-18-21
  5. Narayanaswami P., Verity R., Vissing J. Novel treatments for myasthenia gravis. Int Rev Neurobiol 2025;183:133–60. doi: 10.1016/bs.irn.2025.08.001
  6. Okuno T., Koizumi N., Yasumizu Y. Pathogenesis of thymoma-associated myasthenia gravis: a narrative review. Mediastinum 2025;9:26. doi: 10.21037/med-25-28
  7. O’Connor L., Barnett-Tapia C. Myasthenia gravis in women. Int Rev Neurobiol 2025;183:45–58. doi: 10.1016/bs.irn.2025.04.020
  8. Beeching F., Lecchi A., Riccitelli G.C. Female gender and quality of life outcomes in myasthenia gravis: a systematic review and meta-analysis. Ther Adv Neurol Disord 2025;18:17562864251344742. doi: 10.1177/17562864251344742
  9. Zhou R., Li T., Tian K., Huang L. Exploration the effect of air pollution on the incidence of myasthenia gravis: an empirical study from Chengdu. Atmospheric Pollution Research 2025;16(5):102477. doi: 10.1016/j.apr.2025.102477
  10. Yoshikawa H., Adachi Y., Nakamura Y. et al. Comparative study of Japanese nationwide epidemiological studies of myasthenia gravis using datasets of 2006 and 2018. PLoS One 2025;20(10):e0334041. doi: 10.1371/journal.pone.0334041
  11. Shao T., Lu J., Kang H. et al. Diabetes mellitus in patients with myasthenia gravis: a systematic review and meta-analysis. Endocrine 2025;88(1):24–35. doi: 10.1007/s12020-024-04143-1
  12. Croitoru C.G., Pavel-Tanasa M., Cuciureanu D.I. et al. Autoimmune and non-autoimmune comorbidities in myasthenic patients of East-European descent: a case-control study. J Clin Med 2024;13(8):2273. doi: 10.3390/jcm13082273

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2025 Berg A.V., Kutlubaev M.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77-44264 от  25.08.2023.